Anne Wojcicki, CEO of 23andMe, speaks at a 2013 announcement for the Breakthrough Prize in Life Sciences at UC San Francisco. The genetic testing company said last week that it has received federal approval to reintroduce some health-screening tools.
Anne Wojcicki, CEO of 23andMe, speaks at a 2013 announcement for the Breakthrough Prize in Life Sciences at UC San Francisco. The genetic testing company said last week that it has received federal approval to reintroduce some health-screening tools. Jeff Chiu Associated Press file
Anne Wojcicki, CEO of 23andMe, speaks at a 2013 announcement for the Breakthrough Prize in Life Sciences at UC San Francisco. The genetic testing company said last week that it has received federal approval to reintroduce some health-screening tools. Jeff Chiu Associated Press file